Bristol Myers' stock decline in response to weak guidance is a gift to investors
- Posted on February 6, 2025
- By CNBC
- 1 Views
Bristol Myers' stock decline in response to weak guidance is a gift to investors
The heart of our investment thesis in the drugmaker remains intact.
